Simvastatin attenuates renal ischemia/reperfusion injury from oxidative stress via targeting Nrf2/HO-1 pathway.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Experimental and Therapeutic Medicine

• Publication date

  2017-11-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.3892/etm.2017.5023PMID 29067120PMCID PMC5647698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Simvastatin induces heme oxygenase-1 via NF-E2-related factor 2 (Nrf2) activation through ERK and PI3K/Akt pathway in colon cancer

  2016cited by this paper
• Nephroprotective Effect of Gelsemine Against Cisplatin-Induced Toxicity is Mediated Via Attenuation of Oxidative Stress

  2015cited by this paper
• Activation of Nrf2 by ischemic preconditioning and sulforaphane in renal ischemia/reperfusion injury: a comparative experimental study.

  2015cited by this paper
• Oxymatrine ameliorates renal ischemia-reperfusion injury from oxidative stress through Nrf2/HO-1 pathway.

  2015cited by this paper
• Protective effect of N-acetylcysteine (NAC) on renal ischemia/reperfusion injury through Nrf2 signaling pathway

  2014cited by this paper
• Atorvastatin treatment attenuates renal injury in an experimental model of ischemia–reperfusion in rats

  2014cited by this paper
• Donor Simvastatin Treatment Prevents Ischemia‐Reperfusion and Acute Kidney Injury by Preserving Microvascular Barrier Function

  2013cited by this paper
• The effects of honey supplementation on seminal plasma cytokines, oxidative stress biomarkers, and antioxidants during 8 weeks of intensive cycling training.

  2012cited by this paper
• Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress.

  2012cited by this paper
• The protective mechanism of ligustrazine against renal ischemia/reperfusion injury.

  2011cited by this paper
• Atorvastatin improving renal ischemia reperfusion injury via direct inhibition of active caspase-3 in rats

  2011cited by this paper
• Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K/Akt pathway.

  2010cited by this paper
• Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure.

  2010cited by this paper
• Mitochondria-Targeted Cytoprotective Peptides for Ischemia–Reperfusion Injury

  2008cited by this paper
• Simvastatin activates Keap1/Nrf2 signaling in rat liver

  2008cited by this paper
• Acute protective effects of simvastatin in the rat model of renal ischemia-reperfusion injury: it is never too late for the pretreatment.

  2008cited by this paper
• Molecular Mechanisms Activating the Nrf2-Keap1 Pathway of Antioxidant Gene Regulation

  2005cited by this paper
• Nrf2 signaling in coordinated activation of antioxidant gene expression.

  2004cited by this paper
• Ischemia/reperfusion injury.

  2002cited by this paper
• Postischemic acute renal failure is reduced by short-term statin treatment in a rat model.

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• The evolution of free radicals and oxidative stress.

  2000cited by this paper
• Reactive oxygen species and acute renal failure.

  2000cited by this paper
• Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts.

  1999cited by this paper
• Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats.

  1999cited by this paper
• Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation.

  1999cited by this paper
• Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury.

  1999cited by this paper
• Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.

  1998cited by this paper
• Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

  1995cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Regulation of the mevalonate pathway

  1990cited by this paper
• In vivo generation of hydrogen peroxide by rat kidney cortex and glomeruli.

  1989cited by this paper
• Oxygen-derived free radicals in postischemic tissue injury.

  1985cited by this paper

• Molecular networking based on UPLC-MS/MS fingerprinting for evaluation of Atriplex lindleyi Moq. subsp. inflata's renoprotective potential

  2026cites this paper
• Neuroprotective effects of Simvastatin against alcohol-induced oxidative stress and neurodegeneration in the Hippocampus of adolescent mice

  2025cites this paper
• Immunomodulation by Simvastatin: A Key Mechanism in Attenuating Methotrexate-Induced Kidney Injury Through NF-κB and Oxidative Stress

  2025cites this paper
• Effects of Ezetimibe, Statins, and Their Combination on Nuclear Factor Erythroid 2‑Related Factor 2/Heme Oxygenase-1/Kelch-like ECH-Associated Protein‑1 Signaling and Inflammatory Markers in Indomethacin-Induced Gastric Ulcer in Rats.

  2025cites this paper
• Core signaling pathways in renal ischemia-reperfusion injury: network regulation and therapeutic prospects.

  2025cites this paper
• Pharmacological activation of Nrf2: Cardioprotective effects of statins and metformin against dyslipidemia-induced oxidative stress.

  2025cites this paper
• Bioprospecting hydroxylated chalcones in in vitro model of ischemia-reoxygenation and probing NOX4 interactions via molecular docking

  2024cites this paper
• Baicalin-loaded Polydopamine modified ZIF-8 NPs inhibits myocardial ischemia/reperfusion injury in rats

  2024cites this paper
• Effects of Mineralocorticoid Receptor Blockade and Statins on Kidney Injury Marker 1 (KIM-1) in Female Rats Receiving L-NAME and Angiotensin II

  2023cites this paper
• The roles of liver sinusoidal endothelial cells in liver ischemia/reperfusion injury

  2023cites this paper
• Simvastatin reduces high uric acid-induced oxidative stress and inflammatory response in vascular endothelial cells via nuclear factor E2-related factor 2 (Nrf2) signaling

  2023cites this paper
• Co-administration of angiotensin II and simvastatin triggers kidney injury upon heme oxygenase-1 deficiency.

  2023cites this paper
• Topical combined Phyllanthus emblica Linn. and simvastatin improves wound healing in diabetic mice by enhancing angiogenesis and reducing neutrophil infiltration

  2023cites this paper
• Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases

  2022cites this paper
• Renoprotective Effect of KLF2 on Glomerular Endothelial Dysfunction in Hypertensive Nephropathy

  2022cites this paper
• Regulation of Mitochondrial Homeostasis and Nrf2 in Kidney Disease: Timing Is Critical

  2022cites this paper
• PCSK9 and Other Metabolic Targets to Counteract Ischemia/Reperfusion Injury in Acute Myocardial Infarction and Visceral Vascular Surgery

  2022cites this paper
• Possible Implication of Nrf2, PPAR-γ and MAPKs Signaling in the Protective Role of Mangiferin against Renal Ischemia/Reperfusion in Rats

  2022cites this paper
• The effects of amantadine on lung tissue in lower limb ischemia/reperfusion injury model in rats

  2021cites this paper
• Penehyclidine hydrochloride ameliorates renal ischemia reperfusion-stimulated lung injury in mice by activating Nrf2 signaling

  2021cites this paper
• Renal Ischemia/Reperfusion Early Induces Myostatin and PCSK9 Expression in Rat Kidneys and HK-2 Cells

  2021cites this paper
• Therapeutic hypothermia effect on asphyxial cardiac arrest-induced renal ischemia/reperfusion injury via change of Nrf2/HO-1 levels

  2021cites this paper
• Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy

  2021cites this paper
• Simvastatin Attenuates Abdominal Aortic Aneurysm Formation Favoured by Lack of Nrf2 Transcriptional Activity

  2020cites this paper
• Protective Role of Nrf2 in Renal Disease

  2020cites this paper
• Photobiomodulation promotes neural regeneration when compared to simvastatin treatment in a sciatic nerve crush model

  2020cites this paper
• Comparison of the protective effects of selective endothelin-a receptor antagonist, ambrisentan, and dual endothelin-A/B receptor antagonist, bosentan, in experimental renal ischemia reperfusion injury.

  2020cites this paper
• Effects of ATRA on diabetic rats with renal ischemia-reperfusion injury

  2020cites this paper
• Evaluation of pheniramine maleate and zofenopril in reducing renal damage induced by unilateral ureter obstruction. An experimental study

  2019cites this paper
• Effects of Prolonged Dietary Curcumin Exposure on Skeletal Muscle Biochemical and Functional Responses of Aged Male Rats

  2019cites this paper
• Survival differences of patients with ureteral versus pelvicalyceal tumours: a systematic review and meta-analysis

  2019cites this paper
• Simvastatin Alleviates Intestinal Ischemia/Reperfusion Injury by Modulating Omi/HtrA2 Signaling Pathways.

  2019cites this paper
• Melatonin attenuates acute kidney ischemia/reperfusion injury in diabetic rats by activation of the SIRT1/Nrf2/HO-1 signaling pathway

  2018cites this paper